This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Shoumo Bhattacharya: Innovator in Transcriptional Response Modulation
Introduction
Shoumo Bhattacharya is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biomedical research, particularly in understanding how transcriptional responses can be modified in response to hypoxia. His work has implications for therapeutic and diagnostic methods, showcasing the intersection of innovation and healthcare.
Latest Patents
Shoumo Bhattacharya holds a patent for the identification of compounds that modify transcriptional responses to hypoxia. This invention provides methods for identifying such compounds and their use in therapeutic and diagnostic applications. His innovative approach addresses critical challenges in medical science, particularly in treating conditions related to oxygen deprivation.
Career Highlights
Currently, Shoumo Bhattacharya is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research. His work is characterized by a commitment to improving patient outcomes through innovative solutions. With a focus on transcriptional responses, he is at the forefront of research that could lead to groundbreaking therapies.
Collaborations
Shoumo has collaborated with esteemed colleagues, including David M. Livingston and Andrew L. Kung. These partnerships enhance the depth and breadth of his research, fostering an environment of innovation and discovery.
Conclusion
Shoumo Bhattacharya exemplifies the spirit of innovation in the biomedical field. His contributions, particularly in modifying transcriptional responses to hypoxia, highlight the importance of research in developing new therapeutic strategies. His work continues to inspire advancements in medical science.